Real-world effectiveness of biologic therapies among patients with moderate-to-severe ulcerative colitis in the United States

被引：0
|
作者：
Erin, Comerford [1 ]
Marco, DiBonaventura [2 ]
Timothy, Smith [2 ]
Anthony, Louder [1 ]
David, Gruben [3 ]
Leonardo, Salese [4 ]
Daniel, Quirk [4 ]
机构：
[1] Aetion Inc, New York, NY USA
[2] Pfizer Inc, New York, NY USA
[3] Pfizer Inc, Groton, CT 06340 USA
[4] Pfizer Inc, Collegeville, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P025
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [31] Real-world effectiveness (RWE) of dupilumab in reducing healthcare resource utilization among moderate-to-severe asthma patients
    Pawar, A.
    Blaiss, M. S.
    Modena, B. D.
    Khan, A. H.
    Gomez, L. De Prado
    Zhang, Y.
    Siddiqui, S.
    Jacob-Nara, J. A.
    Gomez, L. De Prado
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [32] Dupilumab Real-world Effectiveness (RWE) in Reducing Healthcare Resource Utilization Among Moderate-to-Severe Asthma Patients
    Modena, B. D.
    Pawar, A.
    Blaiss, M. S.
    Khan, A.
    Gomez, L. De Prado
    Zhang, Y.
    Radwan, A.
    Jacob-Nara, J. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [33] Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States
    Sandborn, William J.
    Sakuraba, Atsushi
    Wang, Anthony
    Macaulay, Dendy
    Reichmann, William
    Wang, Song
    Chao, Jingdong
    Skup, Martha
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (07) : 1233 - 1241
  • [34] Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States
    Sandborn, W.
    Sakuraba, A.
    Wang, A.
    Macaulay, D.
    Schemerold, L.
    Yang, M.
    Skup, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S426 - S426
  • [35] Real-World Experience of Upadacitinib in Treatment of Adults With Moderate to Severe Ulcerative Colitis
    Chowla, Navreet M.
    Tariq, Raseen
    Aggarwal, Manik
    Loftus, Edward V.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S820 - S820
  • [36] REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN ULCERATIVE COLITIS
    Hong, Simon
    Zullow, Samantha
    Axelrad, Jordan
    Chang, Shannon
    Hudesman, David
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 : S73 - S74
  • [37] REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN ULCERATIVE COLITIS
    Hong, Simon
    Zullow, Samantha
    Axelrad, Jordan
    Chang, Shannon
    Hudesman, David
    [J]. GASTROENTEROLOGY, 2020, 158 (03) : S120 - S120
  • [38] Pharmacokinetics of golimumab in patients with moderate-to-severe ulcerative colitis
    Berends, S.
    Strik, A.
    van Egmond, P.
    Brandse, H.
    Mathot, R.
    D'Haens, G.
    Lowenberg, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S424 - S424
  • [39] Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis Registry
    Strober, Bruce
    Ferris, Laura
    Duffin, Kristina Callis
    Janak, Jud C.
    Sima, Adam P.
    Eckmann, Thomas
    Patel, Manish
    Photowala, Huzefa
    Garg, Vishvas
    Armstrong, April
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (01) : 82 - 90
  • [40] Vedolizumab is associated with longer drug sustainability compared to infliximab in moderate-to-severe Ulcerative Colitis: a real-world cohort study
    Konikoff, T.
    Yanai, H.
    Banai, H.
    Avni-Biron, I.
    Snir, Y.
    Broitman, L.
    Barkan, R.
    Checholin, L.
    Dotan, I.
    Ollech, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I463 - I464
12345